entertainment -WSS

entertainment

author：entertainment 2025-09-29 22:36:35 - browse：35

Adobe

WASHINGTON — The Biotechnology Innovation Organization, an industry trade group, is cutting ties with Chinese company WuXi in response to increasing U.S. government scrutiny of it and other Chinese companies, according to a BIO press release shared with STAT on Wednesday.

It’s an about-face for a lobbying organization that recently was willing to defend WuXi against attacks, and it’s a sign that the U.S. biotechnology industry will have to make do without a company that it has come to heavily rely on for developing and making drugs.

WuXi is the only BIO member among the four Chinese companies that would be blacklisted from doing business in the United States by the Biosecure Act, a bipartisan bill that has been introduced in both the House and Senate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Do more moles mean more problems? Not so, says new study

WSS

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

What we know about the American soldier detained in North Korea

Twill hunts for pharma partner to market its depression app

iTeos Therapeutics debuts first data on TIGIT

Manchin plays down potential 3rd

Childbirth

focus

entertainment

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

David Sabatini, ex

The high cost of giving birth even with insurance

Latest bird flu infection made farmworker sicker than earlier cases

New air purifier tech could be key to improving indoor air quality

Johnson & Johnson sues to stop Medicare negotiation

Drug repurposing or repositioning? The language matters

Focused ultrasound for uterine fibroids: an uphill battle

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

UK homeowners get some respite as inflation falls by more than anticipated to a 15

hotspot

Akili, maker of video game for ADHD, to be acquired for 34 million

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

FDA seeking to stop procedures at two unregulated stem cell clinics

Average age of first period drops to 11.9 years, study shows

Focused ultrasound for uterine fibroids: an uphill battle

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

hotspot

focus

knowledge

focus